CompassNow live for financial advisors
Synchron stock

Synchron Stock

HealthTech

Looking to sell Synchron stock or options?

Founded: 2016Funding to Date: $329.4Mhttps://www.synchron.com

Synchron has developed an implantable stentrode aimed at establishing a brain-computer interface. This innovative company provides a minimally invasive device equipped with electrode arrays that decode brain signals to influence neural activity in targeted areas. This technology empowers patients with motor impairments to regain some control over digital devices, prosthetics, or other assistive technologies using just their thoughts.

Notable investors include:
Greenoaks logo
ARCH Venture Partners logo
Khosla Ventures logo
Greenoaks logo
Other investors include:

Bezos Expeditions, Project X, Arani Bose, Moore Strategic Ventures, Forepont Capital Partners, Metis Innovative, re.Mind Capital, Defense Advanced Research Projects Agency, Thomas Reardon, MTPConnect.

Own Synchron stock or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure

Management Team

Joshua DuyanAdvisor
Riki BanerjeeChief Technology Officer
Rahul SharmaCo-Founder, Medical Director & Board Member
Nishant DoctorInvestor Relations
Thomas Oxley Ph.DCo-Founder, Chief Executive Officer & Board Member
Amos MeltzerChief Legal Officer & Chief Operating Officer, Australia
Gary CastroVice President of Finance & Administration
J Mocco MDChief Medical Officer
Kurt HaggstromChief Commercial Officer
Nicholas OpieFounding Director & Board Member

Board Members

Ari Nowacek Ph.DBoard Member
Alexander Morgan Ph.DBoard Member
Robert NelsenBoard Member
Martin DieckBoard Member

Synchron’s stock FAQs